drugset / Trial / NCT00765427
Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers
NaSingle-groupOpen-label
Summary
Healthy volunteer subjects will receive retinoid QLT091001 once-daily for 7 days for safety observation.
Timeline
- Start
- 2008-09
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zuretinol Acetate | Small molecule | — | — |
Indications
No indication recorded.